JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total Bond Market
BND
|
+$2.29B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.1B |
| 3 |
Vanguard Total International Bond ETF
BNDX
|
+$1.67B |
| 4 |
AbbVie
ABBV
|
+$1.6B |
| 5 |
ExxonMobil
XOM
|
+$1.5B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Bond ETF
BSV
|
+$3.99B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.33B |
| 3 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$1.15B |
| 4 |
Tesla
TSLA
|
+$1.05B |
| 5 |
iShares TIPS Bond ETF
TIP
|
+$1.04B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.04% |
| 2 | Healthcare | 10.96% |
| 3 | Financials | 10.87% |
| 4 | Consumer Discretionary | 8.6% |
| 5 | Industrials | 7.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CFB
4201
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
| $846K | ﹤0.01% |
53,674
-51,350
| -49% | -$813K |
|
4202
Bioceres Crop Solutions
BIOX
$28.7M
| $844K | ﹤0.01% |
62,000
-40,325
| -39% | -$532K |
|
4203
CALL
Roblox
RBLX
$27.3B
| $842K | ﹤0.01% |
+18,200
| New | +$1.1M |
|
4204
First Mid Bancshares
FMBH
$1.38B
| $834K | ﹤0.01% |
21,681
-9,221
| -30% | -$379K |
|
4205
VEON
VEON
$3.93B
| $833K | ﹤0.01% |
48,822
+3,683
| +8% | +$100K |
|
|
MTTR
4206
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
| $833K | ﹤0.01% |
102,767
-860
| -0.8% | -$8.15K |
|
|
FPI
4207
Farmland Partners
FPI
$433M
| $832K | ﹤0.01% |
60,483
+6,227
| +11% | +$75.5K |
|
|
MTEM
4208
DELISTED
Molecular Templates, Inc.
MTEM
| $832K | ﹤0.01% |
16,068
-126
| -0.8% | -$5.57K |
|
4209
Mercantile Bank Corp
MBWM
$1.06B
| $831K | ﹤0.01% |
23,464
-14,128
| -38% | -$528K |
|
4210
State Street SPDR Nuveen ICE Municipal Bond ETF
TFI
$3.17B
| $829K | ﹤0.01% |
17,321
-3,819,624
| -100% | -$190M |
|
|
TSPQ
4211
DELISTED
TCW Special Purpose Acquisition Corp.
TSPQ
| $829K | ﹤0.01% |
85,000
-115,000
| -58% | -$1.12M |
|
4212
Phibro Animal Health
PAHC
$1.39B
| $828K | ﹤0.01% |
41,468
-40,479
| -49% | -$817K |
|
|
BCLI
4213
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
| $827K | ﹤0.01% |
16,413
+3,535
| +27% | +$174K |
|
4214
PUT
Boston Scientific
BSX
$75.1B
| $824K | ﹤0.01% |
18,600
-773,100
| -98% | -$33.5M |
|
4215
Grupo Cibest SA
CIB
$22.8B
| $824K | ﹤0.01% |
19,306
-66,164
| -77% | -$2.39M |
|
4216
MediciNova
MNOV
$64.5M
| $823K | ﹤0.01% |
308,276
+7,110
| +2% | +$17.4K |
|
4217
First Trust Large Cap Value AlphaDEX Fund
FTA
$1.44B
| $818K | ﹤0.01% |
11,595
| – | – |
|
4218
Vanguard Intermediate-Term Bond ETF
BIV
$28.8B
| $817K | ﹤0.01% |
9,971
-15,038
| -60% | -$1.27M |
|
|
MORF
4219
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $816K | ﹤0.01% |
20,348
+3,825
| +23% | +$160K |
|
4220
RPC Inc
RES
$1.41B
| $815K | ﹤0.01% |
76,326
-63,700
| -45% | -$508K |
|
|
HMTV
4221
DELISTED
Hemisphere Media Group, Inc.
HMTV
| $815K | ﹤0.01% |
178,121
-15,498
| -8% | -$93.2K |
|
4222
CytomX Therapeutics
CTMX
$732M
| $814K | ﹤0.01% |
305,032
-2,197
| -0.7% | -$8.44K |
|
|
BASE
4223
DELISTED
Couchbase
BASE
| $813K | ﹤0.01% |
46,673
+40,825
| +698% | +$828K |
|
4224
GCM Grosvenor
GCMG
$2.81B
| $804K | ﹤0.01% |
82,872
-51,322
| -38% | -$507K |
|
4225
iShares US Telecommunications ETF
IYZ
$1.23B
| $804K | ﹤0.01% |
26,923
-49,708
| -65% | -$1.52M |
|
Similar funds
JP Morgan Chase's Q1 2022 Portfolio in Review
As of Q1 2022, JP Morgan Chase held 7,378 positions worth $830B, down 4.1% from $866B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q1 2022 filing shows 607 new, 2,657 increased, 2,665 reduced and 679 closed positions. Its largest new stake was iShares AAA-A Rated Corporate Bond ETF: 4,681,132 shares worth $243M. The largest sale was Vanguard Short-Term Bond ETF, an estimated $3.99B.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Healthcare and Financials.
- JP Morgan Chase's largest Q1 2022 buy was iShares AAA-A Rated Corporate Bond ETF: 4,681,132 shares worth $243M.
- JP Morgan Chase added most to Vanguard Total Bond Market in Q1 2022, an estimated $2.29B increase.
- JP Morgan Chase's biggest Q1 2022 reduction was Vanguard Short-Term Bond ETF, cutting an estimated $3.99B.
- JP Morgan Chase fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $442M.
- JP Morgan Chase's ten largest holdings make up 18% of its $830B portfolio in Q1 2022.
- JP Morgan Chase opened 607 new positions and closed 679 in Q1 2022.
- JP Morgan Chase's portfolio value fell 4.1% quarter-over-quarter to $830B.
Based on JP Morgan Chase's 13F filing for Q1 2022, filed 11 May 2022.